MedTrace Logo

Immune Health Biomarkers and Fecal Microbiota in Filipino Breastfed Infants

NCT06708559 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2026-04-03

No results posted yet for this study

Summary

This will be a prospective observational study aiming to investigate immune health biomarkers and fecal microbiota in 48-60 Filipino breastfed infants from birth to 12 months of age. An optional follow-up period of approximately 2 years will follow.

Conditions

  • Healthy

Interventions

OTHER

Breast-fed infants

Immune system characterization via blood and stool samples collection

Sponsors & Collaborators

  • Asian Hospital and Medical Center, Muntinlupa City, Philippines

    collaborator UNKNOWN

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Maria Rosario JK Capeding, MD · Asian Hospital and Medical Center, Philippines

Eligibility

Min Age
14 Days
Max Age
35 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-29
Primary Completion
2026-01-30
Completion
2026-08-31

Countries

  • Philippines

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06708559 on ClinicalTrials.gov